The problem with Biden’s soft stance on cannabis

Last month, the DEA revealed it would reclassify cannabis down from Schedule I to a Schedule III – another blessing from President Biden for Big Pharma, the Spectator commented. “It’s a nasty narrative that cannabis advocates wanted to prevent.”